-
1.
公开(公告)号:US06949585B2
公开(公告)日:2005-09-27
申请号:US10473568
申请日:2002-04-01
IPC分类号: A61K31/12 , A61K31/235 , A61K31/24 , A61K31/4402 , A61P1/04 , A61P1/16 , A61P3/10 , A61P13/12 , A61P17/00 , A61P19/02 , A61P27/02 , A61P29/00 , A61P43/00 , C07C49/657 , C07C49/747 , C07C49/753 , C07C205/57 , C07D207/12 , C07D401/04 , C07D453/02 , C07C69/76 , C07C205/00
CPC分类号: C07D401/04 , A61K31/12 , A61K31/235 , A61K31/24 , A61K31/4402 , C07C49/657 , C07C49/747 , C07C49/753 , C07C205/57 , C07D207/12 , C07D453/02
摘要: The present invention provides a compound which has cytokine production inhibitory activity and is useful for the treatment of diseases which is associated with cytokine. The compound is represented by the following general formula (I) [wherein A represents a cyclic group which may be substituted; the partial structure -DE- represents a group represented by —CH2CH2— or —CH═CH—; W represents a group represented by —CH2—, —CH2CH2—, —CH═CH— or —CH═; the partial structure >XY— represents a group represented by >CH—(CH2)n—, >C═CH—, >CH—CH2—CH(OH)—, >CH—CH2—C(═O)—, >CH—O— or >CH—O—CO—, provided that when W is —CH═, then XY— represents C—(CH2)p—; Z represents a divalent aliphatic hydrocarbon group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a hydroxyl, alkoxy or alkoxyalkoxy group; m is an integer of 0 or 1].
摘要翻译: 本发明提供具有细胞因子产生抑制活性的化合物,可用于治疗与细胞因子相关的疾病。 该化合物由以下通式(I)表示[其中A表示可以被取代的环状基团; 部分结构-D E-表示由-CH 2 CH 2 - 或-CH-CH-表示的基团。 W表示由-CH 2 - , - CH 2 CH 2 - , - CH-CH-或-CH-表示的基团。 部分结构> X Y-表示由CH-(CH 2)n - ,> C-CH-,CH -CH 2 OH(OH) - ,> CH-CH 2 -C(-O) - ,> CH-O-或> CH-O-CO- 条件是当W是-CH-时,则X Y-表示C-(CH 2) Z表示二价脂族烃基; R 1和R 2可以相同或不同,各自表示氢原子,或羟基,烷氧基或烷氧基烷氧基; m为0或1的整数]。
-
公开(公告)号:US07915306B2
公开(公告)日:2011-03-29
申请号:US10657910
申请日:2003-09-09
申请人: Kenichi Chiba , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Ray Wood , Satoshi Yamamoto , Naoki Yoneda
发明人: Kenichi Chiba , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Ray Wood , Satoshi Yamamoto , Naoki Yoneda
IPC分类号: A61K31/335
CPC分类号: C07D493/04 , C07D313/00
摘要: The present invention provides compositions comprising compounds having formula (I): and additionally provides methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein. In certain embodiments, the compositions are for systemic (e.g., oral) administration. In certain embodiments, methods for the treatment of various disorders including inflammatory or autoimmune disorders comprise systemically (e.g., orally) administering to a subject in need thereof a therapeutically effective amount of a compound of formula (I).
摘要翻译: 本发明提供了包含具有式(I)的化合物的组合物:另外提供了其用于治疗各种疾病(包括炎性或自身免疫性疾病)以及涉及恶性肿瘤或增加血管发生的疾病的方法,其中R1-R11,X,Y, Z和n如本文所定义。 在某些实施方案中,组合物用于全身(例如口服)给药。 在某些实施方案中,用于治疗各种疾病(包括炎性或自身免疫性疾病)的方法包括全身(例如,口服)向有需要的受试者施用治疗有效量的式(I)化合物。
-
公开(公告)号:US07799827B2
公开(公告)日:2010-09-21
申请号:US10507067
申请日:2003-03-07
申请人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
发明人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
IPC分类号: A61K31/335 , C07D313/00
CPC分类号: C07D405/12 , A61K31/335 , A61K31/36 , A61K31/395 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/00 , C07D401/12 , C07D491/04 , C07D491/044 , C07D493/04 , Y02A50/411
摘要: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein.
摘要翻译: 本发明提供了具有式(I)的化合物:另外提供了其合成方法及其用于治疗各种疾病(包括炎性或自身免疫性疾病以及涉及恶性肿瘤或增加血管发生的疾病)的方法,其中R1-R11, X,Y,Z和n如本文所定义。
-
公开(公告)号:US08329742B2
公开(公告)日:2012-12-11
申请号:US12839873
申请日:2010-07-20
申请人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
发明人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
IPC分类号: A61K31/355 , C07D313/00
CPC分类号: C07D405/12 , A61K31/335 , A61K31/36 , A61K31/395 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/00 , C07D401/12 , C07D491/04 , C07D491/044 , C07D493/04 , Y02A50/411
摘要: The present invention provides methods for the use of compounds having formula (I) in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, t, X, Y, Z, and n are as defined herein.
摘要翻译: 本发明提供了使用具有式(I)的化合物在治疗各种疾病(包括炎性或自身免疫性疾病)以及涉及恶性肿瘤或增加血管发生的疾病的方法,其中R1-R11,t,X,Y,Z和n 如本文所定义。
-
公开(公告)号:US20110144101A1
公开(公告)日:2011-06-16
申请号:US12839873
申请日:2010-07-20
申请人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
发明人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-André Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
IPC分类号: A61K31/5377 , A61K31/335 , A61K31/4184 , A61P29/00 , A61P37/00 , A61P17/06 , A61P11/06 , A61P35/00 , A61P1/00
CPC分类号: C07D405/12 , A61K31/335 , A61K31/36 , A61K31/395 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/00 , C07D401/12 , C07D491/04 , C07D491/044 , C07D493/04 , Y02A50/411
摘要: The present invention provides methods for the use of compounds having formula (I) in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, t, X, Y, Z, and n are as defined herein.
摘要翻译: 本发明提供了使用具有式(I)的化合物在治疗各种疾病(包括炎性或自身免疫性疾病)以及涉及恶性肿瘤或增加血管发生的疾病的方法,其中R1-R11,t,X,Y,Z和n 如本文所定义。
-
公开(公告)号:US20130196987A1
公开(公告)日:2013-08-01
申请号:US13663857
申请日:2012-10-30
申请人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-Andre Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
发明人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmange , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-Andre Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John (Yuan) Wang , Satoshi Yamamoto , Naoki Yoneda
IPC分类号: C07D405/12 , C07D491/044 , C07D313/00
CPC分类号: C07D405/12 , A61K31/335 , A61K31/36 , A61K31/395 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/00 , C07D401/12 , C07D491/04 , C07D491/044 , C07D493/04 , Y02A50/411
摘要: The present invention provides compounds, methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis.
摘要翻译: 本发明提供了化合物,其合成方法及其用于治疗各种疾病(包括炎性或自身免疫性疾病)以及涉及恶性肿瘤或增加血管生成的疾病的方法。
-
公开(公告)号:US20060247448A1
公开(公告)日:2006-11-02
申请号:US10507067
申请日:2003-03-07
申请人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmanage , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-Andre Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John Wang , Satoshi Yamamoto , Naoki Yoneda
发明人: Roch Boivin , Kenichi Chiba , Jesse Chow , Hong Du , Yoshihito Eguchi , Masanori Fujita , Masaki Goto , Fabian Gusovsky , Jean-Christophe Harmanage , Atsushi Inoue , Yimin Jiang , Megumi Kawada , Takatoshi Kawai , Yoshiyuki Kawakami , Akifumi Kimura , Makoto Kotake , Yoshikazu Kuboi , Charles-Andre Lemelin , Xiang-Yi Li , Tomohiro Matsushima , Yoshiharu Mizui , Kenzo Muramoto , Hideki Sakurai , Yong-Chun Shen , Hiroshi Shirota , Mark Spyvee , Isao Tanaka , John Wang , Satoshi Yamamoto , Naoki Yoneda
IPC分类号: C07D313/08
CPC分类号: C07D405/12 , A61K31/335 , A61K31/36 , A61K31/395 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/00 , C07D401/12 , C07D491/04 , C07D491/044 , C07D493/04 , Y02A50/411
摘要: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein.
摘要翻译: 本发明提供具有式(I)的化合物:另外提供其合成方法及其用于治疗各种疾病(包括炎性或自身免疫性疾病)以及涉及恶性肿瘤或增加血管发生的疾病的方法,其中R 1,R 11,X,Y,Z和n如本文所定义。
-
公开(公告)号:US06649822B2
公开(公告)日:2003-11-18
申请号:US09971685
申请日:2001-10-09
申请人: Yoshihito Eguchi , Takashi Tomita
发明人: Yoshihito Eguchi , Takashi Tomita
IPC分类号: H01L3105
CPC分类号: H01L31/02008 , H02S20/23 , H02S40/36 , Y02B10/12 , Y02E10/50 , Y10S136/291
摘要: According to a method for mounting a plurality of solar battery modules, an underlying member (roofing member) is fixed at a location where the solar battery modules are to be mounted. The underlying member has a wiring made of conductive material that is formed for drawing electric power from the solar battery modules and has connection terminals at respective positions to be connected with each solar battery module. Connection terminals of each solar battery module are coupled with the connection terminals of the underlying member to fasten each solar battery module.
-
公开(公告)号:US5453524A
公开(公告)日:1995-09-26
申请号:US199231
申请日:1994-02-22
申请人: Katsuya Tagami , Ichirou Yoshida , Naoki Kobayashi , Yoshio Fukuda , Yoshihito Eguchi , Makoto Nakagawa , Hironobu Hiyoshi , Hironori Ikuta , Makoto Kaino , Kenji Hayashi , Issei Ohtsuka , Shinya Abe , Shigeru Souda
发明人: Katsuya Tagami , Ichirou Yoshida , Naoki Kobayashi , Yoshio Fukuda , Yoshihito Eguchi , Makoto Nakagawa , Hironobu Hiyoshi , Hironori Ikuta , Makoto Kaino , Kenji Hayashi , Issei Ohtsuka , Shinya Abe , Shigeru Souda
IPC分类号: A61K31/66 , A61P3/06 , C07C211/21 , C07C233/03 , C07F9/38 , C07F9/40 , C07F9/02
CPC分类号: C07F9/405 , C07C211/21 , C07C233/03 , C07F9/3808 , C07F9/3826 , C07F9/3843 , C07F9/3873 , C07F9/4006 , C07F9/4015 , C07F9/4025
摘要: The present invention provides a phosphorus-containing isoprenoid derivative represented by the following general formula (I) or a pharmacologically acceptable salt thereof, which is useful as a preventive and therapeutic agent for diseases for which a squalene synthetase inhibiting action is efficacious: ##STR1## wherein R.sup.1 and R.sup.2 each represent a hydrogen atom, a lower alkyl, cycloalkyl, alkenyl or alkynyl group, an aryl group which may be substituted, an arylalkyl group in which the aryl group may be substituted, or a heteroaryl or heteroarylalkyl group: R.sup.3 and R.sup.4 each represent a hydrogen atom, a lower alkyl group or an alkali metal; Y represents a group represented by the formula: ##STR2## (wherein R.sup.5 and R.sup.6 each represent a hydrogen atom, a lower alkyl group or an alkali metal or a group represented by the formula: --CO.sub.2 R.sup.7 (wherein R.sup.7 represents a hydrogen atom, a lower alkyl group or an alkali metal); Z represents a group represented by the Formula: --(CH.sub.2).sub.m -- (wherein m is an integer of 0 to 3), a group represented by the formula: --(CH.sub.2).sub.p --CH.dbd.CH--(CH.sub.2).sub.q -- (wherein p is 0 or 1 and q is 1 or 2) or a group represented by the Formula: ##STR3## (wherein R.sup.8 represents a hydrogen atom or a lower alkyl group; A represents an alkylene chain which has 1 to 5 carbon atoms and which may have a substituent on each carbon atom; and r is zero or an integer of 1 to 5); and n is zero or an integer of 1 to 5.
摘要翻译: PCT No.PCT / JP92 / 01082 Sec。 371日期:1994年2月22日 102(e)日期1994年2月22日PCT提交1992年8月27日PCT公布。 公开号WO93 / 04073 日本1993年3月4日。本发明提供由以下通式(I)表示的含磷类异戊二烯衍生物或其药理学上可接受的盐,其可用作抑制角鲨烯合成酶的疾病的预防和治疗剂 作用有效:其中R 1和R 2各自表示氢原子,低级烷基,环烷基,烯基或炔基,可被取代的芳基,芳基可以被取代的芳基烷基 或杂芳基或杂芳基烷基:R 3和R 4各自表示氢原子,低级烷基或碱金属; Y表示由下式表示的基团:其中R 5和R 6各自表示氢原子,低级烷基或碱金属或由下式表示的基团:-CO 2 R 7(其中R 7表示氢原子, 低级烷基或碱金属); Z表示由下式表示的基团: - (CH 2)m - (其中m为0至3的整数),由下式表示的基团: - (CH 2)p-CH = CH-(CH 2)q - (其中p为0或1,q为1或2)或由下式表示的基团:其中R8表示氢原子或低级烷基; A表示亚烷基 具有1至5个碳原子并且在每个碳原子上可以具有取代基的链;并且r为0或1至5的整数); n为0或1至5的整数。
-
公开(公告)号:US5719303A
公开(公告)日:1998-02-17
申请号:US530311
申请日:1995-09-06
申请人: Ichirou Yoshida , Hironori Ikuta , Yoshio Fukuda , Yoshihito Eguchi , Makoto Kaino , Katsuya Tagami , Naoki Kobayashi , Kenji Hayashi , Hironobu Hiyoshi , Issei Ohtsuka , Makoto Nakagawa , Shinya Abe , Shigeru Souda
发明人: Ichirou Yoshida , Hironori Ikuta , Yoshio Fukuda , Yoshihito Eguchi , Makoto Kaino , Katsuya Tagami , Naoki Kobayashi , Kenji Hayashi , Hironobu Hiyoshi , Issei Ohtsuka , Makoto Nakagawa , Shinya Abe , Shigeru Souda
IPC分类号: A61K31/66 , A61K31/675 , A61P3/06 , A61P9/12 , C07F9/38 , C07F9/40 , C07F9/547 , C07F9/572 , C07F9/58 , C07F9/59 , C07F9/60 , C07F9/62 , C07F9/6503 , C07F9/6506 , C07F9/6509 , C07F9/6512 , C07F9/653 , C07F9/6533 , C07F9/6539 , C07F9/6541 , C07F9/655 , C07F9/6553 , C07F9/6558 , C07F9/6574
CPC分类号: C07F9/65746 , C07F9/3808 , C07F9/3826 , C07F9/3839 , C07F9/386 , C07F9/3873 , C07F9/4006 , C07F9/4015 , C07F9/4025 , C07F9/404 , C07F9/405 , C07F9/4056 , C07F9/4075 , C07F9/5721 , C07F9/5727 , C07F9/5728 , C07F9/582 , C07F9/588 , C07F9/591 , C07F9/592 , C07F9/598 , C07F9/60 , C07F9/62 , C07F9/65038 , C07F9/65061 , C07F9/65068 , C07F9/650958 , C07F9/650994 , C07F9/65127 , C07F9/653 , C07F9/65324 , C07F9/6533 , C07F9/6539 , C07F9/6541 , C07F9/65505 , C07F9/65515 , C07F9/65517 , C07F9/6552 , C07F9/65522 , C07F9/655345 , C07F9/65583 , C07F9/65586 , C07F9/65742
摘要: A phosphonic acid derivative which is useful for medically treating hyperlipemia, represented by the following general formula (I) or a pharmacologically acceptable salt thereof: ##STR1## Representative example of the compound according to the present invention is one represented by the following formula: ##STR2##
摘要翻译: PCT No.PCT / JP94 / 00354 Sec。 371日期:1995年9月6日 102(e)日期1995年9月6日PCT 1994年3月4日PCT公布。 WO94 / 20508 PCT公开号 日期:1994年9月15日由以下通式(I)表示的用于医疗治疗高脂血症的膦酸衍生物或其药理学上可接受的盐:(I)本发明化合物的代表性实例是 一个由以下公式表示:
-
-
-
-
-
-
-
-
-